SIRT1 and endometriosis: Given the involvement of SIRT1 overexpression in the pathogenesis of endometriosis,310 a new clinical trial was expected to start in January 2022 for the evaluation of 9a as a possible treatment of the inflammation associated with endometriosis and of the endometriosis‐mediated in vitro fertilization failure (NCT04184323), but it has been withdrawn due to lack of funding.